Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis.

MULTIPLE SCLEROSIS JOURNAL（2023）

引用 0|浏览11

暂无评分

摘要

In conclusion, our study shows that IFNβ treatment is a potent and targeted epigenetic modifier in multiple sclerosis.

查看译文

关键词

multiple sclerosis, methylation, interferon beta (IFN beta), disease modifying therapy (DMT), inflammation, epigenetics (DNA methylation)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要